AI Helps Parkinson's Patients During Coronavirus Pandemic

Using artificial intelligence technology platforms, researchers are doing virtual studies to evaluate speech disorders related to Parkinson's disease, said Jessica Huber, a professor of Speech, Language, and Hearing Sciences and associate dean for //research in Purdue's College of Health and Human Sciences, who leads Purdue's Motor Speech Lab.

Huber and her team have been working to develop telepractice tools for the assessment and treatment of speech impairments like Parkinson's disease.

Artificial Intelligence in Healthcare - An Overview
Artificial intelligence (AI) in healthcare is the discipline using data intensive computer based solutions to improve patient care and outcome.

‘New artificial intelligence technology helps patients with Parkinson's disease during COVID-19 pandemic, stated a new study.’

Tweet it Now

They received a National Institutes of Health small business innovation and research grant to develop a telehealth platform to facilitate the provision of speech treatment with the SpeechVive device, which has received attention at the Annual Convention of the American Speech-Language-Hearing Association.

In the current study, Huber and her team are collaborating with a startup company, Modality AI, which developed the AI platform that will be used in the study.

"The application of the technology we are evaluating may lead to far-reaching insights into more standardization in assessments, earlier diagnoses and possibly an easier way to track discrete changes over time to guide interventions," said Andrew Exner, a graduate research assistant in the Motor Speech Lab.

Nutritional Management of Parkinson's Disease
Parkinson's disease is a brain disorder which leads to many other related effects. Nutrition plays an important role in management of the disease.

"My personal research passion, and the mission of our lab, is to find ways to improve the quality of life for people with Parkinson's and other related diseases."

Exner is leading the virtual study for participants across the country to evaluate an AI platform that can collect and automatically measure the speech skills of people with Parkinson's disease.

Quiz on Parkinson’s Disease
Parkinson's disease (PD) is a chronic and progressive nervous system disorder that results in a gradual loss of muscle control. It has an impact on the body's ability to control movement.

The need for AI platforms is increasing as the use of telepractice explodes as a result of the COVID-19 pandemic.

"My interest in speech-language pathology actually started during my training as an actor and opera singer," Exner said. "I saw the effects of pathology on the voice and wanted to extend that interest into speech disorders."

New Artificial Intelligence Platform Detects COVID-19
New artificial intelligence (AI) platform – DeepCOVID-XR can detect COVID-19 at a much faster rate.

SpeechVive Inc. is an Indiana startup company based on Huber's research. The company has developed a wearable medical device to improve the speech clarity of people with Parkinson's.

Source-Eurekalert